• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.

作者信息

Schwab R S, England A C

出版信息

Trans Am Neurol Assoc. 1969;94:85-90.

PMID:4907453
Abstract
摘要

相似文献

1
Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Trans Am Neurol Assoc. 1969;94:85-90.
2
[Treatment of Parkinson's disease with amantadine].
Therapeutique. 1972 Nov;48(9):555-60.
3
L-dopa and amantadine hydrochloride in Parkinson's disease.
Int Z Klin Pharmakol Ther Toxikol. 1971 Apr;4(3):356-60.
4
[Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Rev Neurol (Paris). 1970 Feb;122(2):145-8.
5
[Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Schweiz Med Wochenschr. 1972 Apr 22;102(16):583-6.
6
Treatment of Parkinson's disease with amantadine and L-Dopa.
Eur Neurol. 1972;7(4):228-40. doi: 10.1159/000114429.
7
[Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
Minerva Med. 1970 Jul 4;61(53):2895-903.
8
The treatment with L-dopa and amantadine in Parkinson's disease.
Ther Hung. 1975;23(1):12-6.
9
[Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Med Klin. 1974 Mar 29;69(13):541-5.
10
Treatment of Parkinson's disease with amantadine (Symmetrel).
Psychiatr Neurol Neurochir. 1972 Jan-Feb;75(1):49-59.

引用本文的文献

1
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.开发治疗帕金森病非多巴胺能策略的未来方向
Curr Neuropharmacol. 2024;22(10):1606-1620. doi: 10.2174/1570159X21666230731110709.
2
Amantadine Treatment for Hyperkinetic Movements in Chorea-Acanthocytosis.金刚烷胺治疗舞蹈病-棘红细胞增多症的运动亢进
Mov Disord Clin Pract. 2022 Dec 20;10(2):346-347. doi: 10.1002/mdc3.13623. eCollection 2023 Feb.
3
The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications.
病原体和抗感染药物在帕金森病中的作用：从病因学到治疗意义。
J Parkinsons Dis. 2022;12(1):27-44. doi: 10.3233/JPD-212929.
4
Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells.盐酸金刚烷胺对牛角膜内皮细胞的毒性作用。
Sci Rep. 2021 Sep 16;11(1):18514. doi: 10.1038/s41598-021-98005-9.
5
Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia.左旋多巴诱导运动障碍的药物治疗新进展
Drugs. 2019 Sep;79(13):1367-1374. doi: 10.1007/s40265-019-01170-5.
6
SNAP25 Gene Polymorphisms Protect Against Parkinson's Disease and Modulate Disease Severity in Patients.SNAP25 基因多态性可预防帕金森病并调节患者的疾病严重程度。
Mol Neurobiol. 2019 Jun;56(6):4455-4463. doi: 10.1007/s12035-018-1386-0. Epub 2018 Oct 17.
7
NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.NMDA 拮抗剂治疗帕金森病的非运动症状。
Transl Psychiatry. 2018 Jun 15;8(1):117. doi: 10.1038/s41398-018-0162-2.
8
Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.帕金森病及其管理：第3部分：非多巴胺能和非药物治疗选择
P T. 2015 Oct;40(10):668-79.
9
Amantadine in Parkinson's disease.金刚烷胺在帕金森病中的应用。
Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.
10
Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.盐酸金刚烷胺（Symmetrel）用于帕金森病的治疗：一项双盲交叉研究。
Can Med Assoc J. 1971 Jul 10;105(1):42-6 passim.